Berlin Conference to Explore Future of Personalized Medicine
Berlin, Thursday, 12 December 2024.
Global experts will gather in Berlin for the EP PerMed Conference to discuss advancements in personalized medicine, impacting diagnostics, therapy, and big data application in healthcare.
Conference Details and Scope
The EP PerMed Conference on Personalised Medicine Research, scheduled for February 11-12, 2025, will convene at the Hotel Palace Berlin, bringing together up to 300 participants [1]. This inaugural conference represents a significant milestone in the field of personalized medicine, featuring plenary and parallel sessions covering critical areas such as methodologies in personalized medicine, prevention strategies, and specialized focus on women’s health and pediatric medicine [1].
Expert Perspectives and Leadership
The conference will feature prominent speakers including Dr. Seema Mital, who leads the Cardiac Precision Medicine program at SickKids, bringing expertise in childhood heart disease research and biobank establishment [1]. Dr. Christophe Le Tourneau, a senior Medical Oncologist at Institut Curie, will share insights from groundbreaking clinical trials, including the SHIVA01 trial that compared targeted therapy to conventional chemotherapy [1]. The event’s significance is underscored by EP PerMed Coordinator Wolfgang Ballensiefen, who emphasizes the opportunity for intensive discussions and knowledge exchange [1].
Industry Recognition and Recent Developments
The timing of this conference is particularly relevant given recent industry developments. Just this week, on December 10, 2024, healthŌme received the 2024 Global Innovation Award for advancing personalized, genomics-driven healthcare [5], demonstrating the rapidly evolving landscape of precision medicine. This recognition highlights the growing integration of genomics-based services into healthcare systems and insurance programs [5], themes that will likely be explored during the conference.
Research and Implementation Focus
The conference will address the expanding scope of precision medicine, reflecting the field’s evolution as documented in current academic literature. According to recent publications, precision medicine now encompasses biomarker discovery, clinical genomics, targeted therapies, and pharmacogenomics [3]. The conference will also feature a specialized Training Workshop on Research Integrity, limited to 25-30 participants [1], emphasizing the importance of maintaining high scientific standards in this rapidly advancing field.